vial of semaglutide SkinnyRx: Injectable (GLP-1) Semaglutide / Cyanocobalamin Injection |

Some patients experience temporary appetite loss or mild nausea on GLP-1 medications, which can reduce food intake below what sertraline-treated patients typically maintain

However, dose-dependent gastrointestinal effects limit efficacy, so drugs with GLP-1 and GCG pharmacology can also target alternative pathways and may expand the therapeutic index (132)

Ongoing Evaluation Brenda checks in regularly with each patient to assess not just weight loss, but how weight loss is happening

Best For Recommendations# Maximum Weight Loss# Recommendation : Tirzepatide Reason : SURMOUNT-1 demonstrated 20.9% weight loss at 15 mg, nearly double orforglipron's 12.4%

Consult with a healthcare professional before making any changes to your health regimen

Physicians must consider individual risk for these side effects prior to initiating treatment